Learn more

WALVAX BIOTECHNOLOGY CO LTD

Overview
  • Total Patents
    20
  • GoodIP Patent Rank
    98,710
  • Filing trend
    ⇩ 33.0%
About

WALVAX BIOTECHNOLOGY CO LTD has a total of 20 patent applications. It decreased the IP activity by 33.0%. Its first patent ever was published in 2010. It filed its patents most often in China. Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are PROXIMA CONCEPTS LTD, EVAXION BIOTECH APS and 2CUREX APS.

Patent filings in countries

World map showing WALVAX BIOTECHNOLOGY CO LTDs patent filings in countries
# Country Total Patents
#1 China 20

Patent filings per year

Chart showing WALVAX BIOTECHNOLOGY CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Qian Wen 15
#2 Chen Yuqiu 10
#3 Ma Bo 9
#4 Wang Lili 8
#5 Wang Ming 7
#6 Shi Jing 7
#7 Chen Min 6
#8 Wu Kai 5
#9 Chen Nanping 5
#10 Huang Zhen 5

Latest patents

Publication Filing date Title
CN110804097A Method for simultaneously preparing two monoclonal antibodies
CN109652590A A kind of strand RNA molecular biology for detection of hepatitis A virus and application
CN108079286A A kind of 13 valency pneumococcal polysaccharide-protein combination compositions and its preparation method and application
CN108159408A A kind of multivalent pneumococcal polysaccharide-protein combination compositions and its preparation method and application
CN107436350A A kind of separation method that each composition in mixture is carried out using ELISA Plate and monoclonal antibody
CN107261130A It is a kind of with preparation methods of the DSC as the bacterial polysaccharide protein combined vaccine of activator
CN106039881A Air filtering system and application thereof
CN106399257A Monoclonal antibody capable of resisting group A meningococcal capsular polysaccharide conjugate, hybridoma cell strain and applications
CN105969736A Hepatitis-B-paratyphoid-fever-resistant O-SP monoclonal antibody, hybridoma cell strain and application
CN104911151A Tetanus toxoid resisting monoclonal antibody, hybridoma cell strain for producing antibody, and application of antibody
CN104706596A Method for preparing influenza vaccine lipidosome
CN104592408A Method for purifying capsular polysaccharide
CN104587461A Typhoid and paratyphoid A and B polysaccharide-protein conjugated polyvalent combined vaccine
CN104558225A Extraction method of capsular polysaccharide for intestinal bacteria
CN104383532A Bacterial polysaccharide protein conjugate vaccine using hepatitis B surface antigen as carrier protein and preparation method of bacterial polysaccharide protein conjugate vaccine
CN104195235A Method for detecting purity of CpG ODN sequence and application of method
CN104101596A Detection method for complement-mediated serum antibody-dependent bactericidal activity
CN103468649A Rapid adaptation method of rabies vaccine virus strains for human body on diploid cells of human body
CN103304679A Large-scale preparing and purifying method of bacteria O-specific polysaccharide
CN101745109A Method for preparing nasal-spray type influenza virus vaccine containing CpG ODN and poly I:G adjuvant